Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Antiarrhythmic drugs are considered to terminate atrial fibrillation by prolonging refractoriness, but direct experimental evaluation of this concept has been limited. The atria are activated rapidly during atrial fibrillation, and antiarrhythmic drugs are known to have important rate-dependent actions. The potential role of such properties in determining drug effects during atrial fibrillation has not been evaluated. METHODS AND RESULTS: We evaluated the effects of representative class Ia (procainamide), Ic (propafenone), and III (sotalol) antiarrhythmic drugs on sustained cholinergic atrial fibrillation and atrial electrophysiological properties in anesthetized, open-chest dogs. Loading and maintenance doses were used to produce stable plasma concentrations, and computer-based 112-electrode epicardial mapping was used to study atrial conduction and activation during atrial fibrillation. Clinically used doses of procainamide and propafenone terminated atrial fibrillation in 13 of 13 (100%) and 7 of 10 (70%) dogs, respectively, but a dose of sotalol (2 mg/kg IV) in the clinical range terminated atrial fibrillation in only 2 of 8 (25%) dogs (P = .0005 vs procainamide, P = .08 vs propafenone). Procainamide and propafenone prevented atrial fibrillation induction in 13 of 13 (100%) and 7 of 10 (70%) dogs, respectively, compared with none of 8 dogs for 2 mg/kg sotalol (P < .0001 vs procainamide, P = .004 vs propafenone). A larger dose of sotalol (cumulative dose, 8 mg/kg) was uniformly effective in terminating atrial fibrillation and preventing its induction. All drugs significantly increased atrial refractory period, with effects that were use dependent for propafenone but reverse use dependent for sotalol. Effective doses of all drugs significantly increased the wavelength for reentry at rapid atrial rates in the presence of vagal stimulation into the range observed under drug-free conditions in the absence of vagal input. The inefficacy of clinical doses of sotalol was explained by the reverse use dependence of its effects on refractoriness, which resulted in reduced effects on wavelength at rapid rates. The effects of propafenone on refractoriness were significantly increased at rapid rates, contributing to its ability to increase wavelength and terminate atrial fibrillation. Activation mapping showed that drugs terminated atrial fibrillation by reducing the number and increasing the size of reentry circuits, leading to termination by mechanisms related to block in the remaining circuit(s). CONCLUSIONS: We conclude that antiarrhythmic drugs terminate experimental atrial fibrillation by increasing the wavelength for reentry at rapid rates, leading to a reduction in the number of functional reentry circuits and, eventually, failure of reentrant excitation. Use-dependent effects on refractoriness can limit (in the case of the reverse use dependence of sotalol) or contribute (in the case of propafenone) to antiarrhythmic drug efficacy against atrial fibrillation by determining drug-induced changes in wavelength at rapid atrial rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats
Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,494
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
KLÉBER, A. G., & RUDY, Y. (2004) · Physiological Reviews · doi:10.1152/physrev.00025.2003 · Cited by 1,083
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation
Jalife, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00223-7 · Cited by 587
Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 486
Gaspo, R., Bosch, R. F., Talajic, M., & Nattel, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4027 · Cited by 409
Self-citationTieleman, R. G., Van Gelder, I. C., Crijns, H. J. G. M., De Kam, P. J., Van Den Berg, M. P., Haaksma, J., Van Der Woude, H. J., & Allessie, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00455-5 · Cited by 408
Rotors and the Dynamics of Cardiac Fibrillation
Pandit, S. V., & Jalife, J. (2013) · Circulation Research · doi:10.1161/circresaha.111.300158 · Cited by 404
Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria
Tieleman, R. G., De Langen, C. D. J., Van Gelder, I. C., de Kam, P. J., Grandjean, J., Bel, K. J., Wijffels, M. C. E. F., Allessie, M. A., & Crijns, H. J. G. M. (1997) · Circulation · doi:10.1161/01.cir.95.7.1945 · Cited by 340
Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes
Tan, H. L., Hou, C. J. Y., Lauer, M. R., & Sung, R. J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-9-199505010-00009 · Cited by 268
Tachycardia-Induced Changes in Na+Current in a Chronic Dog Model of Atrial Fibrillation
Gaspo, R., Bosch, R. F., Bou-Abboud, E., & Nattel, S. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1045 · Cited by 256
Self-citationMechanisms of Atrial Fibrillation: Lessons From Animal Models
Nattel, S., Shiroshita-Takeshita, A., Brundel, B. J. J. M., & Rivard, L. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.06.002 · Cited by 244
Self-citationElectrophysiologic mechanisms of perpetuation of atrial fibrillation
Allessie, M. A., Konings, K., Kirchhof, C. J. H. J., & Wijffels, M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89114-x · Cited by 203
Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1997) · Circulation · doi:10.1161/01.cir.96.12.4298 · Cited by 156
“[9,10,12,13,16] In contrast, in the group with a short mean AF CL, although ibutilide increased AF CL, wavelength may not have prolonged sufficiently to critically reduce the number of wavelets and allow the arrhythmia to terminate.”
Background
Metadata
- Authors
- Wang, J., Bourne, G. W., Wang, Z., Villemaire, C., Talajic, M., & Nattel, S.
- Venue
- Circulation
- Published
- 1993-09
- Volume
- 88
- Issue
- 3
- Pages
- 1030-1044
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1981532308
- Cited by
- 209
- References
- 0
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.